Table of Contents
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
June 10, 2003
GENELABS TECHNOLOGIES, INC.
California | 0-19222 | 94-3010150 | ||
(State of Incorporation) | (Commission File No.) | (IRS Employer Identification No.) |
505 Penobscot Drive, Redwood City, California 94063
(650) 369-9500
ITEM 5. OTHER INFORMATION | ||||||||
ITEM 7. EXHIBITS | ||||||||
SIGNATURE | ||||||||
EXHIBIT INDEX | ||||||||
EXHIBIT 99.1 |
Table of Contents
ITEM 5. OTHER INFORMATION
On June 10, 2003, Genelabs Technologies, Inc. issued a press release announcing and providing highlights from a corporate update to be presented at the Registrant’s annual meeting of shareholders.
ITEM 7. EXHIBITS
99.1 Press Release of Registrant, dated June 10, 2003, entitled “Genelabs to Provide Corporate Update at Annual Shareholder Meeting”
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.
GENELABS TECHNOLOGIES, INC. | ||||
By: | /s/ Matthew M. Loar | |||
Name: Matthew M. Loar Title: Chief Financial Officer | ||||
Date: June 10, 2003 |
Table of Contents
EXHIBIT INDEX
EXHIBIT NO. | DESCRIPTION | |
99.1 | Press Release of Registrant, dated June 10, 2003, entitled “Genelabs to Provide Corporate Update at Annual Shareholder Meeting” |